8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT PURSUANT TO

SECTION 13 OR 15(D) OF

THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported):      July 5, 2016

ALLEGHANY CORPORATION

(Exact name of registrant as specified in its charter)

Delaware	1-9371	51-0283071
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer     Identification No.)

1411 Broadway, 34th Floor, New York, New York	10018
(Address of principal executive offices)	(Zip Code)

Registrant’s telephone number, including area code:  (212) 752-1356

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[    ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[    ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[    ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[    ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 7.01      Regulation FD Disclosure.

On July 5, 2016, Transatlantic Reinsurance Company (“TransRe”), an indirect, wholly owned subsidiary of Alleghany Corporation (“Alleghany”), issued a press release announcing that it has entered into an agreement with General Reinsurance Corporation (“Gen Re”), a wholly owned subsidiary of Berkshire Hathaway Inc., for an initial five-year term, for TransRe to act as exclusive underwriting manager on behalf of Gen Re for U.S. and Canadian property and casualty treaty reinsurance business produced by brokers and intermediaries.

A copy of the press release containing the announcement is furnished herewith as Exhibit 99.1.

The information hereunder shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be incorporated by reference into a filing under the Securities Act of 1933, as amended or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Forward-Looking Statements

Certain statements contained in this document may be deemed to be “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may include, without limitation, statements relating to the terms of the agreement with Gen Re (including certain projections and business trends, and statements which may be identified by the use of the words “plans,” “expects” or “does not expect,” “estimated,” “is expected,” “budget,” “scheduled,” “estimates,” “forecasts,” “intends,” “anticipates” or “does not anticipate,” or “believes,” or variations of such words and phrases or statements that certain actions, events or results “may,” “could,” “would,” “might,” “will” or “will be taken,” “occur” or “be achieved”). Forward-looking statements do not relate solely to historical or current facts, but are rather based on management’s expectations as well as certain assumptions and estimates made by, and information available to, management at the time. These forward-looking statements are based upon Alleghany’s current expectations and are subject to a number of uncertainties and risks that could significantly affect current plans, anticipated actions and Alleghany’s future financial condition and results. These statements are not guarantees of future performance. Factors that could cause these forward-looking statements to differ, possibly materially, from that currently contemplated include the factors set forth in Alleghany’s most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q filed with the United States Securities and Exchange Commission. All forward-looking statements speak only as of the date they are made and are based on information available at that time. Alleghany does not undertake any obligation to update or revise any forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements were made or to reflect the occurrence of unanticipated events except as required by federal securities laws.

Item 9.01      Financial Statements and Exhibits.

(d) Exhibits. The following exhibits are being furnished herewith:

Exhibit No.	Description of Exhibit
99.1	Press Release, dated July 5, 2016.

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	ALLEGHANY CORPORATION
Date:  July 5, 2016	By:	/s/ Christopher K. Dalrymple
		Name:	Christopher K. Dalrymple
		Title:	Senior Vice President, General    Counsel and Secretary

3

EX-99.1

Exhibit 99.1

Gen Re and TransRe Form Exclusive Broker Market Underwriting Relationship

TransRe to Manage Gen Re’s Broker Market Treaty Business in U.S. and Canada Under 5-year Agreement

NEW YORK, NY, July 5, 2016 – General Reinsurance Corporation (“Gen Re”), a wholly owned subsidiary of Berkshire Hathaway Inc. (NYSE:BRK), and Transatlantic Reinsurance Company (“TransRe”), a wholly owned subsidiary of Alleghany Corporation (NYSE:Y), jointly announced today that they have entered into an initial five-year agreement for TransRe to act as exclusive underwriting manager on behalf of Gen Re for U.S. and Canadian property and casualty treaty reinsurance business produced by brokers and intermediaries.

This new arrangement provides brokers and intermediaries access to Gen Re’s traditionally direct-only capacity through a new underwriting platform fully managed by TransRe. By leveraging TransRe’s underwriting acumen, claims expertise and broker relationships across the combined financial strength of the two companies, the new facility will deliver enhanced solutions to the reinsurance market including broader capacity and line size, while providing consistency and assurance in execution.

“This arrangement between Gen Re and TransRe creates a unique and compelling new capability in the North American broker reinsurance market. We are combining the strengths, capacity, and reputations of two outstanding organizations to enable improved panel diversification and creditworthiness with one-stop seamless service,” said TransRe President and CEO Michael Sapnar.

Kara Raiguel, Gen Re President and CEO, commented, “We are enthusiastic about partnering with TransRe to bring Gen Re’s industry-leading security to clients through the brokered market. TransRe’s proven underwriting track record and excellent broker relationships make them the ideal partner for Gen Re for this important long-term strategic initiative.”

The facility is expected to be available for U.S. and Canadian broker market treaty business written on and after August 1, 2016, subject to applicable regulatory approvals or authorizations.

Additional information regarding the agreement can be found at www2.transre.com/in-the-news/.

About Gen Re

Gen Re, a Berkshire Hathaway Company, is one of the leading Property/Casualty and Life/Health reinsurers in the world, with a global network of branch and subsidiary offices in key reinsurance markets. Gen Re is rated A++ (Superior) and AA+ by AM Best and Standard & Poor’s, respectively. For more information, visit www.genre.com.

About TransRe

TransRe is a reinsurance organization headquartered in New York with operations worldwide. Since 1978, TransRe has been offering clients the capacity, expertise and creativity necessary to structure programs across the full spectrum of property and casualty risks. TransRe is rated A+ and A by Standard & Poor’s and AM Best, respectively. Visit www.transre.com for additional information.

For further information, please contact:

Jeff Majtyka

JMSC Group

646-776-0886

jeff@jmscgroup.com